![Robert Jahr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: - $ al 30/06/2026
Robert Charles Jahr is President, Chief Executive Officer & Director at Outlook Therapeutics, Inc. since 2025.
Formerly, Mr. Jahr was Chief Commercial Officer at Sobi North America in 2025 and Vice President & Head-International Markets at UCB Pharma SA. Education includes undergraduate and MBA degrees from the University of Montana System.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 18/05/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Director Ejecutivo | 01/07/2025 |
| Empresas | Cargo | Fin |
|---|---|---|
UCB Pharma SA
 UCB Pharma SA Chemicals: SpecialtyProcess Industries Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
UCB Pharma SA
UCB Pharma SA Chemicals: SpecialtyProcess Industries Manufactures pharmaceutical products | Process Industries |
University of Montana System
 University of Montana System Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outlook Therapeutics, Inc.
 Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
